Veradigm Gross Margin 2010-2022 | MDRX
Veradigm Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2022-12-31 | $0.59B | $0.31B | 52.12% |
2022-09-30 | $0.60B | $0.32B | 52.32% |
2022-06-30 | $0.60B | $0.30B | 50.75% |
2022-03-31 | $0.59B | $0.29B | 49.74% |
2021-12-31 | $0.58B | $0.28B | 48.79% |
2021-09-30 | $-0.14B | $0.06B | -43.57% |
2021-06-30 | $0.08B | $0.13B | 155.56% |
2021-03-31 | $0.31B | $0.20B | 63.43% |
2020-12-31 | $0.56B | $0.27B | 47.66% |
2020-09-30 | $1.43B | $0.48B | 33.75% |
2020-06-30 | $1.51B | $0.52B | 34.66% |
2020-03-31 | $1.58B | $0.57B | 35.93% |
2019-12-31 | $1.63B | $0.61B | 37.38% |
2019-09-30 | $1.63B | $0.62B | 37.91% |
2019-06-30 | $1.62B | $0.62B | 38.38% |
2019-03-31 | $1.62B | $0.61B | 37.83% |
2018-12-31 | $1.62B | $0.62B | 38.47% |
2018-09-30 | $1.52B | $0.60B | 39.71% |
2018-06-30 | $1.53B | $0.63B | 40.83% |
2018-03-31 | $1.52B | $0.64B | 42.09% |
2017-12-31 | $1.50B | $0.63B | 42.28% |
2017-09-30 | $1.55B | $0.69B | 44.19% |
2017-06-30 | $1.49B | $0.65B | 43.47% |
2017-03-31 | $1.45B | $0.63B | 43.26% |
2016-12-31 | $1.39B | $0.60B | 43.40% |
2016-09-30 | $1.47B | $0.64B | 43.44% |
2016-06-30 | $1.43B | $0.63B | 43.68% |
2016-03-31 | $1.40B | $0.60B | 43.13% |
2015-12-31 | $1.39B | $0.58B | 41.89% |
2015-09-30 | $1.38B | $0.56B | 40.74% |
2015-06-30 | $1.37B | $0.54B | 39.40% |
2015-03-31 | $1.37B | $0.54B | 39.14% |
2014-12-31 | $1.38B | $0.55B | 39.58% |
2014-09-30 | $1.39B | $0.55B | 39.44% |
2014-06-30 | $1.37B | $0.54B | 39.50% |
2014-03-31 | $1.37B | $0.54B | 39.39% |
2013-12-31 | $1.37B | $0.53B | 38.89% |
2013-09-30 | $1.37B | $0.53B | 38.75% |
2013-06-30 | $1.40B | $0.56B | 40.10% |
2013-03-31 | $1.43B | $0.58B | 40.87% |
2012-12-31 | $1.45B | $0.61B | 41.88% |
2012-09-30 | $1.48B | $0.65B | 43.53% |
2012-06-30 | $1.49B | $0.65B | 43.78% |
2012-03-31 | $1.47B | $0.66B | 44.91% |
2011-12-31 | $1.44B | $0.67B | 46.12% |
2011-09-30 | $1.37B | $0.64B | 46.36% |
2011-06-30 | $1.25B | $0.60B | 47.84% |
2011-03-31 | $1.08B | $0.54B | 49.35% |
2010-09-30 | $0.62B | $0.33B | 53.97% |
2010-06-30 | $0.56B | $0.31B | 56.04% |
2010-03-31 | $0.53B | $0.30B | 56.66% |
2010-02-28 | $0.51B | $0.29B | 55.84% |
2009-09-30 | $0.49B | $0.26B | 53.16% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.482B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $39.307B | 54.29 |
Hims & Hers Health (HIMS) | United States | $13.112B | 136.23 |
Tempus AI (TEM) | United States | $10.781B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.503B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.415B | 68.98 |
Privia Health (PRVA) | United States | $3.036B | 207.50 |
Enovis (ENOV) | United States | $2.041B | 11.38 |
Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
Schrodinger (SDGR) | United States | $1.706B | 0.00 |
Phreesia (PHR) | United States | $1.529B | 0.00 |
Omnicell (OMCL) | United States | $1.315B | 23.21 |
Azenta (AZTA) | United States | $1.223B | 56.83 |
10x Genomics (TXG) | United States | $1.125B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.610B | 0.00 |
Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
Talkspace (TALK) | United States | $0.500B | 149.50 |
Claritev (CTEV) | United States | $0.450B | 0.00 |
Standard BioTools (LAB) | United States | $0.399B | 0.00 |
TruBridge (TBRG) | United States | $0.368B | 816.67 |
Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.147B | 0.00 |
Pulmonx (LUNG) | United States | $0.138B | 0.00 |
American Well (AMWL) | United States | $0.117B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
CareCloud (CCLD) | United States | $0.086B | 3.27 |
Outset Medical (OM) | United States | $0.070B | 0.00 |
111 (YI) | China | $0.067B | 0.00 |
P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
Zhongchao (ZCMD) | China | $0.032B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |